Sidebar is Loading...
Sign In
Brands
Resources
Stories
YSTV
ADVERTISEMENT
Sign In
Brands
Resources
Stories
YSTV
Developing bioprinted tissue therapeutics to transform how we treat disease.
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases.
Legal Name
:
Aspect Biosystems Ltd
Headquarters
:
vancouver, British Columbia, Canada
Founding Date
:
2013
No. of Employees
:
61 to 100
Core Team
:
1.
Tamer Mohamed
Founder and CEO
2.
Simon Beyer
Co-Founder and CTO
3.
Sam Wadsworth
Co-Founder and CSO
4.
Eric Roos
Chief Business Development Officer
See More
Total Funding
$27.6M
Investors
:
1.
National Research Council of Canada Industrial Research Assistance Program
2.
Pangaea Ventures
3.
Innovate BC
4.
Genome British Columbia
See More
Frequently Asked Questions
